|
Weekly Update | June 14, 2010 |
|
|
Microsoft and Yahoo
Announce Changes to Online Advertising of Pharmaceuticals
The Partnership for Safe
Medicines (PSM) commends mainstream search engines Microsoft and Yahoo for
their recent decision requiring U.S. pharmaceutical advertisers to be
accredited by the Verified Internet Pharmacy Practice Sites (VIPPS) program
in order to advertise online.
Google was the first engine
to require pharmaceutical advertisers to be VIPPS-accredited, a
move the PSM commended and encouraged other search engines to emulate.
|
|
The changes will place a
much-needed barrier between rogue Internet pharmacies and unwitting consumers,
said PSM Vice President Bryan Liang, MD, PhD, JD.
"Last year, my
research group published the first study identifying the patient safety risks
of buying from search engine-sponsored online drug sellers that used suspect
third party "verification" services that did little to ensure patient
safety," said Dr. Liang. "Confirming our work, other assessments have
found that 80 to 90 percent of search engine-sponsored online pharmacies
violated federal and state laws-including the sale of substandard and
counterfeit drugs and addictive controlled substances without a
prescription," said Liang. "We believe that online pharmacies need to
follow the same rules as their brick-and-mortar counterparts, and this is a
significant step toward mitigating the threat of unsafe medicines available for
purchase online."
Scott LaGanga, PSM's
executive director, agreed adding, "This is a major turning point in the
arena of Internet pharmacies, one that will help make the online marketplace
safer for Americans."
When asked to comment,
Carmen Catizone, the executive director of the National Association of Boards
Pharmacy (NABP), which created the VIPPS program, voiced enthusiasm over the
changes.
"This change among
major search engines is a significant win for patient safety," said
Catizone. "VIPPS-accredited websites are important resources for consumers
and will help them make informed choices about where to purchase
medications."
The new requirements will
also have an impact on illicit drug sellers. "We'll see rogue websites
adversely affected by these changes through a loss of business," added
Catizone. "However, we need to dedicate more funds to regulatory agencies
including the Food and Drug Administration (FDA) and the Drug Enforcement
Authority (DEA) so that they are better equipped to prevent illicit
pharmaceutical products from entering the supply system."
Echoing
these sentiments, LaGanga noted that "Criminals selling counterfeit or
unapproved drugs online are beyond the reach of FDA regulators and
investigators. We're in need of resources, as well as new legislation that
prohibits financial transactions for drug sales of unlicensed online
pharmacies, and creates substantive penalties for any party that engages in the
illegal sale of counterfeit and contraband drugs." |
Top News
Profitability
of Counterfeit Drugs Necessitates Improved Prevention Techniques
Scott
LaGanga, director of the Partnership for Safe Medicines, says that consumers
often trust the supply chain to deliver an authentic product, yet in much of
the developing world this trust could be broken because it's become so
profitable to distribute, sell, and manufacture counterfeit drugs. Nigeria's
government is fighting to keep consumers' trust using mobile phone technology.
"We have developed a technology which makes it easy for consumers to
authenticate medication at the point of purchase. There is a scratch panel - just
like a lottery ticket with number on the drug - each drug has a different
number. When you buy a drug, you scratch the panel, you send a text message
with the number that you see, and you get a response instantly at the counter
if the drug is genuine or fake," said Ashifi Gogo, who heads the phone
company. ("Counterfeit Medicines Grow as Global Threat," Voice of America,
June 7, 2010; Story
here)
|
World News
Customs
Officers From Around the Globe Unite to Fight Counterfeit Drugs Counterfeit
drugs have become a $200-billion-a-year industry and the 176-nation World
Customs Organization (WCO) will sign a declaration later this month to fight
the scourge, an official said on Thursday. On June 24, 176 national customs
chiefs will sign a declaration to ban the making and marketing of counterfeit
drugs. "We have more fakes than real drugs in the market," said
Christophe Zimmermann, the WCO's anti-counterfeiting and piracy coordinator. Western
Europeans spend an estimated 10.5 billion euros ($14.3 billion) a year on
illicitly sourced medicines. In a sign Europe is taking the issue seriously too,
justice ministers on the Council of Europe are set to ratify a convention on
counterfeit drugs in Istanbul
this November. ("Customs group to fight $200 Bln Bogus Drug Industry," Reuters,
June 10, 2010; Story
here) Taiwan: Anti-Drug Task Force Leads to
Increase in Counterfeit Drug Cases The number
of cases in May involving the illegal sale of counterfeit drugs increased
significantly after the formation of a Cabinet anti-drug task force in April, Department
of Health (DOH) Minister Yaung Chih-liang said Thursday. In May, the number of
illegal drug cases averaged 204 per week and 96 were referred to law
enforcement agencies. This was a sharp increase from April when drug cases
averaged 48 cases per week and 11 were referred to law enforcement authorities.
Most of the illegal drugs seized were weight-loss products, lifestyle drugs and
anti-inflammatory painkillers. ("Illegal Drug Cases Increase After Formation of
Task Force: DOH," Focus Taiwan, June 10, 2010; Story
here) |
Events
5th Global Pharma Manufacturing SummitWhen: Monday, Jun 14, 2010 Where: Boston, MA Description: Link
here Global Pharma Authentication When: Monday, Jun 14, 2010 Where: Munich, Germany Description: Link here 4th Annual Pharmaceutical Anti-Counterfeiting Strategies
Conference When: Tuesday, Sep 7, 2010 Where: London, UK Description: Link here
PSM's Inaugural 2010
Interchange When: Friday, Oct 8, 2010 Where: Washington, D.C. Description: The Partnership for Safe
Medicines invites you to save the date for an intimate conference
bringing together patient groups, providers, pharmaceutical company quality
experts, enforcement personnel, policymakers, regulatory agency experts and
other interested parties to discuss key issues around counterfeit drugs andother unsafe medicines. Link
here. |
|
About the Partnership for Safe Medicines
The Partnership for Safe Medicines is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines. For more information, please visit SafeMedicines.org.
| |
|